Austin Central In The News
Read the latest Austin Central news and stories.
Publication: Austin American-Statesman
3/25/2024 - Texas Oncology has enrolled the first two patients in Texas in an innovative stage 3 clinical trial testing an mRNA vaccine for melanoma treatment. Jeff Yorio, M.D., Texas Oncology-Austin Central, shared how the melanoma vaccine is created, what results are expected and what the trial could mean for the future of melanoma treatment.
Publication: The American Journal of Managed Care
3/12/2024 - The mental health struggle that accompanies a cancer diagnosis is real, and the burden of dealing with so many conflicting emotions falls not only on the patients but also on their caregivers, families, friends, and physicians. Kathryn E. Hudson, M.D., director of survivorship and medical oncologist at Texas Oncology-Austin Central explains the complex picture of emotions patients feel throughout their cancer journey and why mental health support should be a part of all cancer care.
Publication: KTBC-TV (FOX, Austin)
2/8/2024 - Rebecca L. Wiatrek, M.D., FACS, Texas Oncology Surgical Specialists-Austin Central and Round Rock joined KTBC-TV’s (FOX, Austin) “HealthBeat” segment to discuss stomach cancer, in light of country singer Toby Keith’s recent death by this disease. According to the American Cancer Society, stomach cancer accounts for 1.5% of all new cancer cases diagnosed each year in the U.S., making this disease fairly rare, yet one to know the signs and symptoms for.
Publication: Austin Medical Times, Houston Medical Times
2/2/2024 - When it comes to the heart and cancer treatment, balancing the effectiveness of cancer therapies with the preservation of heart function is essential to improving the long-term cardiovascular health of cancer patients. Karen Cohen, M.D.,Texas Oncology–Austin Central and Round Rock and Andrew Jackson, M.D., Texas Oncology–The Woodlands, share how healthcare providers and cancer patients can make informed decisions when it comes to matters of the heart.
Publication: Austin Medical Times, Houston Medical Times
10/1/2023 - Unlocking the genetic “secrets” inside cancer cells is revolutionizing oncology. This advancement in medical science is the foundation of precision medicine, which provides patients with more personalized and targeted treatment, based on understanding the genetic information of a patient’s cancer.
Publication: SurvivorNet
9/27/2023 - PARP inhibitors have dramatically changed the cancer treatment paradigm, especially for ovarian cancer patient, Melinda Fiebig. Melinda joined SurvivorNet to share how PARP treatment really worked for her – and the best part was it didn’t interrupt her day-to-day life.
Publication: Austin American-Statesman
9/3/2023 - In September 2022, Mark Tempelmeyer, 64, received a call that changed his life. After being diagnosed with stage IV prostate cancer, Mark and his wife Helene aimed to "find him the best in Austin," and he was referred to Kyle T. Keyes, M.D., Texas Urology Specialists–Austin and Austin Midtown, and Mike Lattanzi, M.D., Texas Oncology–Austin Central, to treat his cancer. Now that his most recent PSA score registered at a 0.1, Mike and Helene live a full life together with a fresh perspective.
Publication: KVUE-TV (ABC, Austin)
8/4/2023 - Since December 2022, Keith Westmoreland, patient of Christopher R. Oxner, M.D., FACS, USN, Texas Oncology Surgical Specialists-Austin Central, Cedar Park and South Austin, has been diagnosed with skin cancer four separate times, with two spots on his head and two on his chest. Both Keith and Dr. Oxner joined KVUE-TV (ABC, Austin) to discuss the risks of skin cancer, its symptoms and why this diagnosis is on the rise. In fact, incidence rates for melanoma have been rising rapidly over the past few decades, and in Texas, 4,998 cases of melanoma of the skin are expected in 2023, up 3.2% from 2022.
Publication: SurvivorNet
8/1/2023 - Helen Dinkelspiel Eshed, M.D., Texas Oncology-Austin Central and South Austin was featured in various videos on SurvivorNet discussing the ovarian cancer landscape. Dr. Eshed joined SurvivorNet and dove into the evolving ovarian cancer treatment space discussing topics from the latest guidance on PARP inhibitors, how the new drug Elahere is providing hope to cancer patients, folate receptor–alpha positive ovarian cancer, mirvetuximab soravtansine and more.
Publication: Austin Medical Times, Houston Medical Times, Palestine Herald-Press, Pittsburg Gazette
8/1/2023 - Heading back to school with all of the stresses that come with managing a cancer diagnosis is a daunting challenge. No matter if you’re a student or parental guardian of someone in school, learn how proper planning and support can help make it possible to create the right balance between successfully continuing one’s studies and undergoing cancer treatment.